Physician profile
Mark Wayne Wright
NPI 1770772170
$1,158.84
in general payments reported to CMS, 2019-2025
20 companies · $62.68 in 2025
The $62.68 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $455 · 2022: $185 · 2023: $336 · 2024: $120 · 2025: $62.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $186.07 | 2023-2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $149.61 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.76 | 2021-2023 | Lifevest |
| Amgen INC. | $78.99 | 2021-2022 | |
| Abiomed | $77.98 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.67 | 2021-2022 | |
| Boston Scientific Corporation | $55.70 | 2023-2025 | Eluvia, Carotid Wallstent |
| Novo Nordisk INC | $54.77 | 2023-2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $50.32 | 2021-2022 | |
| Pfizer INC. | $49.79 | 2021-2023 | |
| Inari Medical, INC. | $41.05 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals Lp | $38.95 | 2021 | |
| Abbott Laboratories | $38.22 | 2023 | Cardiomems |
| Amarin Pharma, INC. | $36.89 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.88 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $26.17 | 2021 | |
| Angiodynamics, INC. | $24.84 | 2024 | Alphavac |
| Lilly USA, LLC | $22.59 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.68 | 2023 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.